Case Reports in Oncological Medicine · 2019 · 13 citations · 10 references
MedicineOncologySurgeryBreast OncologyChemotherapySurgical OncologyBreast Cancer OncologyBreast Cancer RecurrenceBreast Cancer SurgeryBreast Surgical OncologyAnthracycline-based ChemotherapyBreast Cancer ChemotherapyDoxorubicin-based TherapyIfosfamide-based TherapyMalignant Breast TumorsMalignant Pleural EffusionPhyllodes Tumor SurgeryRecurrent Pleural Effusion
Malignant phyllodes tumors of the breast occur infrequently and are difficult to treat with chemotherapy. Here, we present an effective chemotherapy strategy for recurrent malignant breast phyllodes tumors. A 48-year-old woman was diagnosed with a malignant phyllodes tumor in her right breast and underwent total right mastectomy. One year later, the tumor recurred in the right (a 2.2 cm mass) and left (a 10 cm mass) lungs; pleural effusion was also observed in the left lung. Eight courses of doxorubicin-ifosfamide (AI) therapy were administered. After treatment, the right lung mass and pleural effusion regressed completely and the left lung mass regressed to 2 cm. In conclusion, AI therapy is useful for treating recurrent malignant breast phyllodes tumors.
10
Axel Le Cesne, Ian Judson, D. Crowther et al. · Journal of Clinical Oncology · 2000 · 258 citations
Medicine, Oncology, Pharmacology +15
Sarcomas and malignant phyllodes tumours of the breast – A retrospective study
C Confavreux, A. Lurkin, N. Mitton et al. · European Journal of Cancer · 2006 · 124 citations
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast
Jerzy Mituś, Paweł Blecharz, Tomasz Walasek et al. · World Journal of Surgery · 2015 · 85 citations · Full text